Dr R Ranga Rao

Medical Oncologist Specialist

Dr (Col.)Ranga is a well-qualified and experienced Medical Oncologist.
Dr Rao has more than 32+ years of experience in the field of Medical Oncology.
Dr R Ranga Rao holds proficiency in managing and treating cancers related to the Lung, Pleura, Breast, Ovarian, Cervical, Esophagus, Stomach, Small Intestine, Colon, Rectum, Liver, Gall Bladder, Pancreas, Bone, Skin, Lymphomas all types, Brain Tumors, Kidney, Urinary Bladder, Prostrate, Head and Neck.
Dr Ranga has been esteemed with several awards and respect.
Dr Ranga Rao’s special interests are Chemotherapy, Targeted Therapy, Hormonal Therapy, Supportive & Palliative Care, and Precision Care.
Dr. (Col.) R Ranga Rao is an active member of various organizations including the American Society of Clinical Oncology ( ASCO), the European Society of Medical Oncology (ESMO), and the Indian Society of Medical and Pediatric Oncology (ISMPO).
Before working with Paras Hospitals, Dr Ranga Rao worked with prestigious healthcare institutions across India.

MBBS, Jawaharlal Nehru Medical College, Ajmer
MD, (Internal Medicine) Armed Forces Medical College, Pune, Maharashtra
DM, (Medical Oncology) Dr Muthulaxmi College of Oncological Sciences, Cancer Institute, Adyar, Chennai

Awarded ‘Vishisht Seva Medal’ by the President of India for meritorious and distinguished service rendered in the Armed Forces on the eve of Republic Day 2006.
Col KK Gupta Memorial Gold Medal 1984 for standing first in the Advance course Medicine 1982-84.
Lt Gen R S Hoon Award 1994 for the original paper entitled “Immuno-phenotyping of Acute Leukaemia”
Best Original Article Award MJAFI 1995 for the original paper entitled “Use of Long–term Venous Access in Patients of Acute Leukaemia and NHL”.
Lt Gen RS Hoon Award 1996, for the original paper entitled “Preliminary analysis of Alpha Interferon Therapy in Chronic Myeloid Leukaemia”.
Air Marshall Ajit Nath Guru Shanti Devi Award 1997 for the original paper entitled “Impact of Prophylactic Use of Colony Stimulating Factors on Neutropenia and Infections in Moderately Intensive Chemotherapy”.
2nd Best Poster Award Merck Serrano Oncology Summit Hong Kong March 2012: Palliative weekly chemotherapy along with cetuximab in recurrent and metastatic head and neck cancers an observational phase IV Retrospective Analysis.

We are the preferred choice of patients travelling to India to seek medical treatments.